Characteristics | Level/type | Value |
---|---|---|
n | Â | 86 |
Sex (%) | F | 40 (46.5) |
M | 46 (53.5) | |
Age (mean (SD)) | Â | 54.59 (15.56) |
Diagnosis (%) | DLBCL | 86 (100.0) |
Therapy (%) | R-CHOP | 86 (100.0) |
Response (%) | CR | 32 (37.2) |
PD | 15 (17.4) | |
PR | 25 (29.1) | |
SD | 14 (16.3) | |
Ann Arbor stage (%) | I | 6 (7.0) |
II | 18 (20.9) | |
III | 7 (8.1) | |
IV | 48 (55.8) | |
Unknown | 7 (8.1) | |
Cell of origin (%) | GCB | 23 (26.7) |
Non-GCB | 61 (70.9) | |
Unknown | 2 (2.3) | |
IPI (%) | 0 | 8 (9.3) |
1 | 12 (14.0) | |
2 | 18 (20.9) | |
3 | 28 (32.6) | |
4 | 15 (17.4) | |
5 | 2 (2.3) | |
Unknown | 3 (3.5) | |
Mean LDH (SD) | Â | 364.33 (326.72) |
Mean β2MG (SD) |  | 2.84 (2.77) |